Rehm, J., Samokhvalov, A. V. & Shield, K. D. Global burden of alcoholic liver diseases. J. Hepatol. 59, 160–168 (2013).
Seitz, H. K. et al. Alcoholic liver disease. Nat. Rev. Dis. Prim. 4, 16 (2018).
World Health Organization. Global Status Report On Alcohol And Health 2018. WHO https://www.who.int/publications/i/item/9789241565639 (2018). Comprehensive work from the World Health Organization that provides global and country/region-level data on alcohol consumption and burden.
Manthey, J. et al. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. Lancet 393, 2493–2502 (2019). An important study that forecasts alcohol exposure in 2030.
GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 392, 1015–1035 (2018).
Crabb, D. W., Im, G. Y., Szabo, G., Mellinger, J. L. & Lucey, M. R. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology 71, 306–333 (2020).
Mathurin, P. & Bataller, R. Trends in the management and burden of alcoholic liver disease. J. Hepatol. 62, S38–S46 (2015).
Article PubMed PubMed Central Google Scholar
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of alcohol-related liver disease. J. Hepatol. 69, 154–181 (2018).
Rehm, J. et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev. 29, 437–445 (2010).
Mathurin, P. et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment. Pharmacol. Ther. 25, 1047–1054 (2007).
Article CAS PubMed Google Scholar
Singal, A. K. & Mathurin, P. Diagnosis and treatment of alcohol-associated liver disease: a review. JAMA 326, 165–176 (2021).
Article CAS PubMed Google Scholar
Collaborators, G. D. A. I. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204–1222 (2020). An important source of data providing peer-reviewed estimates for the burden of liver disease associated with alcohol.
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
Huang, D. Q. et al. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 34, 969–977.e962 (2022). This study utilized data from the Global Burden of Disease Study and determined that alcohol was the second fastest growing cause of liver cancer deaths.
Article CAS PubMed Google Scholar
Paik, J. M., Golabi, P., Younossi, Y., Mishra, A. & Younossi, Z. M. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatology 72, 1605–1616 (2020).
WHO. Global Information System on Alcohol and Health (GISAH). Global Health Observatory https://www.who.int/data/gho/data/themes/global-information-system-on-alcohol-and-health (2016).
Blas, E. and Sivasankara Kurup, A. (eds) Equity, social determinants and public health programmes. Social Determinants of Health (WHO) https://www.who.int/publications/i/item/9789241563970 (2015).
WHO. European action plan to reduce the harmful use of alcohol 2012–2020. WHO https://www.euro.who.int/__data/assets/pdf_file/0008/178163/E96726.pdf (2012).
Schmidt, L. A. & Room, R. Alcohol and inequity in the process of development: contributions from ethnographic research. Int. J. Alcohol Drug Res. 1, 41–55 (2013).
Wang, H., Ma, L., Yin, Q., Zhang, X. & Zhang, C. Prevalence of alcoholic liver disease and its association with socioeconomic status in north-eastern China. Alcohol. Clin. Exp. Res. 38, 1035–1041 (2014).
Charatcharoenwitthaya, P., Liangpunsakul, S. & Piratvisuth, T. Alcohol-associated liver disease: East versus West. Clin. Liver Dis. 16, 231–235 (2020).
Rehm, J. et al. The relationship between different dimensions of alcohol use and the burden of disease-an update. Addiction 112, 968–1001 (2017).
Article PubMed PubMed Central Google Scholar
US Department of Health and Human Services and US Department of Agriculture. 2015–2020 Dietary Guidelines for Americans. health.gov https://health.gov/our-work/nutrition-physical-activity/dietary-guidelines/previous-dietary-guidelines/2015 (2015).
Ritchie, H. Alcohol Consumption (Our World in Data, 2019).
Bellentani, S. et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 41, 845–850 (1997).
Article CAS PubMed PubMed Central Google Scholar
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 5, 245-266, (2020).
Tapper, E. B. & Parikh, N. D. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. Br. Med. J. 362, k2817 (2018).
Julien, J., Ayer, T., Bethea, E. D., Tapper, E. B. & Chhatwal, J. Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019-40: a modelling study. Lancet Public Health 5, e316–e323 (2020).
Toyoda, H., Huang, D. Q., Le, M. H. & Nguyen, M. H. Liver care and surveillance: the global impact of the COVID-19 pandemic. Hepatol. Commun. 4, 1751–1757 (2020).
Article CAS PubMed PubMed Central Google Scholar
Tan, E. X.-X. et al. Impact of COVID-19 on liver transplantation in Hong Kong and Singapore: a modelling study. Lancet Regional Health West. Pacif. https://doi.org/10.1016/j.lanwpc.2021.100262 (2021).
Boettler, T. et al. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic. JHEP Rep. 2, 100169 (2020).
Article PubMed PubMed Central Google Scholar
Li, J. et al. Epidemiology of COVID-19: a systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J. Med. Virol. 93, 1449–1458 (2021).
Article CAS PubMed Google Scholar
Pollard, M. S., Tucker, J. S. & Green, H. D. Jr Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US. JAMA Netw. Open 3, e2022942 (2020).
Article PubMed PubMed Central Google Scholar
The Lancet Gastroenterology, H. Drinking alone: COVID-19, lockdown, and alcohol-related harm. Lancet Gastroenterol. Hepatol. 5, 625 (2020).
Bittermann, T., Mahmud, N. & Abt, P. Trends in liver transplantation for acute alcohol-associated hepatitis during the COVID-19 pandemic in the US. JAMA Netw. Open 4, e2118713–e2118713 (2021).
Article PubMed PubMed Central Google Scholar
Marjot, T. et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. J. Hepatol. 74, 567–577 (2021).
Article CAS PubMed Google Scholar
Julien, J. et al. Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: a modeling study. Hepatology 75, 1480–1490 (2022).
Article CAS PubMed Google Scholar
Akinyemiju, T. et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015. JAMA Oncol. 3, 1683–1691 (2017).
Article PubMed PubMed Central Google Scholar
Altekruse, S. F., Devesa, S. S., Dickie, L. A., McGlynn, K. A. & Kleiner, D. E. Histological classification of liver and intrahepatic bile duct cancers in SEER registries. J. Regist. Manag. 38, 201–205 (2011).
Percy, C., Ries, L. G. & Van Holten, V. D. The accuracy of liver cancer as the underlying cause of death on death certificates. Public Health Rep. 105, 361–367 (1990).
CAS PubMed PubMed Central Google Scholar
Polednak, A. P. Using cancer registries to assess the accuracy of primary liver or intrahepatic bile duct cancer as the underlying cause of death, 1999–2010. J. Regist. Manag. 40, 168–175 (2013).
Hagström, H. et al. Risk of cancer in biopsy-proven alcohol-related liver disease: a population-based cohort study of 3,410 persons. Clin. Gastroenterol. Hepatol. https://doi.org/10.1016/j.cgh.2021.01.005 (2021).
N’Kontchou, G. et al. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. Clin. Gastroenterol. Hepatol. 4, 1062–1068 (2006).
Huang, D. Q. et al. Hepatocellular carcinoma incidence in alcohol-associated cirrhosis: systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. https://doi.org/10.1016/j.cgh.2022.06.032 (2022).
Jepsen, P., Ott, P., Andersen, P. K., Sørensen, H. T. & Vilstrup, H. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study. Ann. Intern. Med. 156, 841–847 (2012).
Ioannou, G. N., Green, P., Kerr, K. F. & Berry, K. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification. J. Hepatol. 71, 523–533 (2019).
Article PubMed PubMed Central Google Scholar
Ganne-Carrié, N. et al. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis. J. Hepatol. 69, 1274–1283 (2018).
留言 (0)